Main Logo

Urinary Comprehensive Genomic Profiling for Detection, Molecular Staging of UTUC

By Stephan Broenimann, MD, Katie S. Murray, DO, MS - Last Updated: May 7, 2024

At the AUA 2024 Annual Meeting, Katie S. Murray, DO, of NYU Langone Urology and Bellevue Hospital, and Stephan Broenimann, MD, of Johns Hopkins University, highlight an evaluation of urinary comprehensive genomic profiling for non-invasive detection and molecular staging in a cohort of patients undergoing treatment for UTUC.

This research, Dr. Broenimann suggests, provides evidence that urinary comprehensive genomic profiling can provide valuable diagnostic and prognostic information for the evaluation for UTUC.

Post Tags:AUAAUA 2024: Focus on Bladder Cancer